Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Renewable Energy Group

Start price
Target price
Perf. (%)
€81.50
26.01.21
€100.00
2.45%
08.02.21

Risky Investment
buy
Cummins Inc.

Start price
Target price
Perf. (%)
€204.00
26.01.21
€225.00
26.01.22
12.75%
08.03.21

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Innovative
Sustainability is important
Orbital Infrastructure Group inc.

Start price
Target price
Perf. (%)
€350.00
26.01.21
€280.00
-19.43%
18.02.21

Could be very worthwhile Investment >20% year
buy
Engie S.A.

Start price
Target price
Perf. (%)
€12.94
26.01.21
€17.00
26.01.22
1.68%
27.01.22

buy
Engie S.A.

Start price
Target price
Perf. (%)
€12.94
26.01.21
€17.00
26.01.22
1.68%
27.01.22

buy
Engie S.A.

Start price
Target price
Perf. (%)
€12.94
26.01.21
€17.00
26.01.22
1.68%
27.01.22

buy
Vossloh AG

Start price
Target price
Perf. (%)
€42.30
26.01.21
€49.00
26.01.22
1.42%
27.01.22

Aemetis Inc.

Start price
Target price
Perf. (%)
€10.10
26.01.21
-
26.01.22
-20.79%
27.01.22

Innovative
High valuation
Low dividend yield expected
Below average Management
Orbital Infrastructure Group inc.

Start price
Target price
Perf. (%)
€274.00
26.01.21
-
26.01.22
-79.12%
27.01.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Supernus Pharmaceuticals

Start price
Target price
Perf. (%)
€25.20
25.01.21
€28.00
25.01.22
3.97%
26.01.22

Could be worthwhile Investment >10% per year
McPhy Energy S.A.

Start price
Target price
Perf. (%)
€35.05
25.01.21
-
25.01.22
-54.78%
06.08.21

Business model of the past or high risk
Higher risks for its business
buy
Sunpower Corp.

Start price
Target price
Perf. (%)
€41.70
25.01.21
€46.00
25.01.22
-65.15%
26.01.22

Revenue growth > 30% per year expected
Could be worthwhile Investment >10% per year
Sustainability is very important
Future proof or reliable business model
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€57.37
25.01.21
€55.00
25.01.22
-68.89%
26.01.22

Could be worthwhile Investment >10% per year
Innovative
Very differentiated customer and product portfolio
Higher risks for its business
Orbital Infrastructure Group inc.

Start price
Target price
Perf. (%)
€212.00
25.01.21
€400.00
25.01.22
-49.43%
19.05.21

High risks for its business
overvalued
Little known brand
buy
Metabolic Explorer

Start price
Target price
Perf. (%)
€2.79
25.01.21
€3.10
25.01.22
50.36%
22.06.21

Could be worthwhile Investment >10% per year
Polar Power Inc

Start price
Target price
Perf. (%)
€20.80
25.01.21
€18.00
25.01.22
-32.69%
28.01.21

Capable Management
Bad culture
Little innovation
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€173.98
25.01.21
€250.00
25.01.22
23.00%
17.01.22

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€199.00
25.01.21
€250.00
25.01.22
-46.48%
17.01.22

Fair valuation
Known brand
Growths faster than the competition
Revenue growth >5% per year expected
buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€2.83
25.01.21
€3.44
25.01.22
24.13%
04.06.21

Small cyclical dependencies
Could be worthwhile Investment >10% per year
Growths faster than the competition
Innovative
buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€2.83
25.01.21
€3.44
25.01.22
24.13%
04.06.21

Small cyclical dependencies
Could be worthwhile Investment >10% per year
Growths faster than the competition
Innovative
buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€2.83
25.01.21
€3.44
25.01.22
24.13%
04.06.21

Small cyclical dependencies
Could be worthwhile Investment >10% per year
Growths faster than the competition
Innovative
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€22.08
25.01.21
€35.00
30.39%
08.02.21

Could be worthwhile Investment >10% per year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group